Managing Emerging Infectious Diseases: Should Travel Be the Fifth Vital Sign?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32120386.
- Also identified by DOI 10.7326/M20-0643 and PMC identifier 7081174.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the setting of emerging infections, such as COVID-19, this commentary argues that all members of the health care team need training on how to integrate key epidemiologic information, such as travel history, into their risk assessments in the same way they are trained to ask about tobacco exposure to assess cancer and heart disease risk.
Medical subject headings
- Communicable Diseases, Emerging
- Travel-Related Illness